David Rhind is Director & 10% at KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU). They have made 1 open-market trade across 1 company since 2015, most recently 2015-09-10.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KEQU | 22,455 | $728K |
Shares reported on the most recent Form 4, priced at the 2015-09-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KEQU | SELL | 2015-09-09 | 2015-09-11 | $16.35 | $164K | -0.1% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.